STAAR Surgical Company (STAA) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

Total Revenue Chart for STAAR Surgical Company

STAAR Surgical Company (STAA) revenue for FY2025 was USD 239.4M, a -23.7% change from FY2024. STAAR Surgical Company's revenue grew from USD 6.8M in 1988 to USD 239.4M in 2025 (3421.2% over 37 years). Earnings per share grew from USD 0.04 in 2011 to USD 0.78 in 2022 (2047.1%). Revenue compound annual growth rate: 5-year CAGR of 7.9%, 10-year CAGR of 12.0%, 20-year CAGR of 8.0%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$1.13B
Implied Share Price
$22.61
Enterprise Value
$1.32B
Revenue (TTM)
$339.59M
EBITDA
$49.76M
Profit Margin
1.13%
Trailing P/E
282.62
Forward P/E
126.58
Price/Book (MRQ)
4.11
Price/Sales (TTM)
3.34
EV/EBITDA
89.62
EV/Revenue
4.55
Dividend Yield
—
Book Value
$7.29
Free Cash Flow (FY2025)
-$40.05M
Free Cash Flow Yield
-3.53%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.